Health Highlights, April 7, 2022

Is the CDC in crisis? Former agency heads debate its future. A handful of former directors say they support a sweeping review of the agency that's been ordered up by current director Dr. Rochelle Walensky. Read more
Experimental pill may fight antibiotic-resistant UTIs. The new pill, called tebipenem HBr, worked as well as a standard IV antibiotic in treating patients hospitalized with "complicated" UTIs, a study has found. Read more
Upped risk for clots lasts at least 6 months after COVID. A new study suggests that COVID-19 is an independent risk factor for deep vein thrombosis, pulmonary embolism and bleeding, researchers say. Read more
U.S. nursing home industry needs an overhaul. A major new report finds facilities awash in ineffective care and staffing shortages. Its authors call for sweeping changes in an industry whose failures have only been exacerbated by the pandemic. Read more
Are retooled COVID booster shots coming this fall? Federal health officials told an expert advisory panel on Wednesday that clinical trials of potential candidates would have to begin by next month, and a final formula chosen by June. Read more
Related Posts
Frailty-Related Fracture Risk Higher for Seniors With Cancer History
THURSDAY, Nov. 3, 2022 (HealthDay News) -- Older adults with a history of cancer...
¿Podría la COVID en el embarazo aumentar el riesgo de obesidad infantil?
MIÉRCOLES, 29 de marzo de 2023 (HealthDay News) -- Todavía se están determinando...
Flu Shots Lag in States With Low COVID Vaccine Uptake
THURSDAY, June 16, 2022 (HealthDay News) -- Adult flu shots have slumped in...
Combined Oral Contraceptives Do Not Seem to Worsen Macromastia
FRIDAY, Oct. 7, 2022 (HealthDay News) -- Use of a combined oral contraceptive...